First Allied Advisory Services’s Elevance Health ELV Stock Holding History

First Allied Advisory Services’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.4M	Sell	5,212 -274	-5%	-$73.7K	0.05%	384
2020 Q2	$1.44M	Sell	5,486 -374	-6%	-$99.8K	0.05%	347
2020 Q1	$1.33M	Sell	5,860 -353	-6%	-$96.2K	0.06%	331
2019 Q4	$1.88M	Sell	6,213 -84	-1%	-$23.1K	0.06%	325
2019 Q3	$1.5M	Sell	6,297 -104	-2%	-$28.5K	0.05%	365
2019 Q2	$1.81M	Buy	6,401 +1,182	+23%	+$323K	0.06%	322
2019 Q1	$1.49M	Buy	5,219 +347	+7%	+$100K	0.05%	359
2018 Q4	$1.28M	Sell	4,872 -655	-12%	-$180K	0.05%	359
2018 Q3	$1.51M	Buy	5,527 +1,541	+39%	+$400K	0.05%	355
2018 Q2	$949K	Buy	3,986 +508	+15%	+$118K	0.04%	470
2018 Q1	$773K	Buy	3,478 +481	+16%	+$113K	0.03%	525
2017 Q4	$676K	Buy	2,997 +1,445	+93%	+$308K	0.03%	552
2017 Q3	$296K	Sell	1,552 -250	-14%	-$47.6K	0.01%	814
2017 Q2	$345K	Sell	1,802 -70	-4%	-$12.6K	0.02%	759
2017 Q1	$310K	Sell	1,872 -2,457	-57%	-$391K	0.02%	772
2016 Q4	$622K	Buy	4,329 +338	+8%	+$45.3K	0.03%	519
2016 Q3	$500K	Buy	3,991 +2,091	+110%	+$270K	0.03%	565
2016 Q2	$252K	Sell	1,900 -12	-0.6%	-$1.64K	0.01%	824
2016 Q1	$268K	Sell	1,912 -1,112	-37%	-$149K	0.01%	781
2015 Q4	$422K	Sell	3,024 -10,813	-78%	-$1.49M	0.02%	649
2015 Q3	$1.95M	Buy	13,837 +10,566	+323%	+$1.59M	0.11%	219
2015 Q2	$532K	Buy	3,271 +195	+6%	+$31.2K	0.02%	599
2015 Q1	$478K	Buy	3,076 +812	+36%	+$116K	0.03%	591
2014 Q4	$292K	Buy	2,264 +565	+33%	+$69.8K	0.02%	766
2014 Q3	$205K	Buy	+1,699	New	+$195K	0.02%	913
2014 Q2	–	Sell	-2,057	Closed	-$203K	–	1032
2014 Q1	$203K	Buy	+2,057	New	+$186K	0.02%	882
2013 Q3	–	Sell	-42,192	Closed	-$3.41M	–	1015
2013 Q2	$3.41M	Buy	+42,192	New	+$3.16M	0.27%	109

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

First Allied Advisory Services's ELV Position: Q3 2020 in Review

First Allied Advisory Services reduced its Elevance Health (ELV) stake by 5% in Q3 2020, selling an estimated $73.7K and leaving 5,212 shares worth $1.4M. The position accounts for 0.05% of the portfolio, ranked #384.

First Allied Advisory Services first reported a position in ELV in Q2 2013 and has held it in 27 quarters since. The position peaked at $3.41M in Q2 2013. 1,095 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

First Allied Advisory Services held 5,212 shares of Elevance Health worth $1.4M as of Q3 2020.
First Allied Advisory Services sold 274 Elevance Health shares in Q3 2020, an estimated $73.7K.
Elevance Health made up 0.05% of First Allied Advisory Services's portfolio in Q3 2020, its #384 holding.
First Allied Advisory Services first reported a position in Elevance Health in Q2 2013 and has held it in 27 quarters since.
First Allied Advisory Services's Elevance Health position peaked at $3.41M in Q2 2013.
1,095 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.